Bagia Jai S, Chai Alan, Chou Roger, Chu Christopher, Rouse John, Sinclair Elizabeth, Vonthethoff Leon, Teixeira-Pinto Armando
Department of Surgery, St George Hospital, Sydney, NSW, Australia.
Department of Radiology, St George Hospital, Sydney, NSW, Australia.
HPB (Oxford). 2015 Oct;17(10):927-35. doi: 10.1111/hpb.12437. Epub 2015 Aug 10.
To assess and compare the accuracy and inter-observer agreement for the detection of liver lesions using Primovist magnetic resonance imaging (pMRI) and computed tomography during arterial portography (CTAP).
Patients evaluated at St George Hospital Liver Unit for colorectal liver metastases (CRCLM) underwent CTAP as part of standard staging. pMRI was added to the pre-operative assessment. Two radiologists reported CTAP and two reported pMRI. The sensitivity and specificity of CTAP and pMRI were calculated using histopathology as the gold standard.
Complete data were available for 62 patients corresponding to 219 lesions confirmed on histopathology. Agreement on the detection of lesions between the two radiologists that reported pMRI was higher than for CTAP (Kappa = 0.80 versus 0.74). Specificity of lesion detection for pMRI was 0.88 and 0.83 for CTAP (P = 0.112). Sensitivity for pMRI was 0.83 and 0.81 for CTAP. For patients who had chemotherapy before evaluation, pMRI had a significantly higher specificity than CTAP (0.79 versus 0.63, P = 0.011).
pMRI is less invasive, has a good inter-observer agreement, has comparable sensitivity and specificity to CTAP in the pre-chemotherapy population and demonstrates better specificity in patients assessed post-chemotherapy. pMRI is a valid alternative to CTAP in the assessment of CRCLM.
评估并比较使用普美显磁共振成像(pMRI)和动脉门静脉造影计算机断层扫描(CTAP)检测肝脏病变的准确性及观察者间的一致性。
在圣乔治医院肝病科接受评估的结直肠癌肝转移(CRCLM)患者接受CTAP检查作为标准分期的一部分。术前评估增加了pMRI检查。两名放射科医生报告CTAP结果,两名报告pMRI结果。以组织病理学为金标准计算CTAP和pMRI的敏感性和特异性。
62例患者有完整数据,对应组织病理学确诊的219个病变。报告pMRI的两名放射科医生在病变检测上的一致性高于CTAP(kappa值分别为0.80和0.74)。pMRI检测病变的特异性为0.88,CTAP为0.83(P = 0.112)。pMRI的敏感性为0.83,CTAP为0.81。对于评估前接受过化疗的患者,pMRI的特异性显著高于CTAP(0.79对0.63,P = 0.011)。
pMRI侵入性较小,观察者间一致性良好,在化疗前人群中与CTAP具有相当的敏感性和特异性,在化疗后评估的患者中特异性更高。在CRCLM评估中,pMRI是CTAP的有效替代方法。